Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Observational Study to Evaluate the Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists for Secondary Thrombosis Prevention in Low-risk Thrombotic Antiphospholipid Syndrome Patients

NCT07372170 is registered in ClinicalTrials.gov with Infanta Leonor University Hospital as lead sponsor.

NCT NCT07372170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07372170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Observational Study to Evaluate the Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists for Secondary Thrombosis Prevention in Low-risk Thrombotic Antiphospholipid Syndrome Patients
Lead sponsor
Infanta Leonor University Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2025
Completion date
December 31, 2028
Enrollment
600 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome (aps), thrombophilia, venous thrombosis (disorder)